190 related articles for article (PubMed ID: 37124485)
1. Development of a prognostic nomogram and risk stratification system for upper thoracic esophageal squamous cell carcinoma.
Lin Y; Zheng B; Chen J; Huang Q; Ye Y; Yang Y; Chen Y; Chen B; You M; Wang Q; Xu Y
Front Oncol; 2023; 13():1059539. PubMed ID: 37124485
[TBL] [Abstract][Full Text] [Related]
2. The Prognostic Significance of Nomogram-Based Pretreatment Inflammatory Indicators in Patients With Esophageal Squamous Cell Carcinoma Receiving Intensity-Modulated Radiotherapy.
Xu Z; Ke H; Zheng B; Lin C; Zhang Y; Wang L; Lin Y; Ye Y; Cai L; You M; Chen J; Xu Y
Cancer Control; 2023; 30():10732748231185025. PubMed ID: 37339928
[TBL] [Abstract][Full Text] [Related]
3. Development and validation of a nomogram to predict overall survival of T1 esophageal squamous cell carcinoma patients with lymph node metastasis.
Yu J; Hu W; Yao N; Sun M; Li X; Wang L; Yang Y; Li B
Transl Oncol; 2021 Aug; 14(8):101127. PubMed ID: 34020370
[TBL] [Abstract][Full Text] [Related]
4. Clinical features and prognostic factors in patients diagnosed with lymphovascular invasion of testicular germ-cell tumors: Analysis based on the SEER database.
Ke H; Jiang S; He Z; Song Q; Yang D; Song C; Dong C; Liu J; Su X; Zhou J; Xiong Y
Front Oncol; 2023; 13():1142441. PubMed ID: 36937437
[TBL] [Abstract][Full Text] [Related]
5. Clinical features and prognostic factors in patients with microvascular infiltration of hepatocellular carcinoma: Development and validation of a nomogram and risk stratification based on the SEER database.
Yang D; Zhu M; Xiong X; Su Y; Zhao F; Hu Y; Zhang G; Pei J; Ding Y
Front Oncol; 2022; 12():987603. PubMed ID: 36185206
[TBL] [Abstract][Full Text] [Related]
6. A prognostic nomogram for the cancer-specific survival of patients with upper-tract urothelial carcinoma based on the Surveillance, Epidemiology, and End Results Database.
Li C; Yang J; Xu F; Han D; Zheng S; Kaaya RE; Wang S; Lyu J
BMC Cancer; 2020 Jun; 20(1):534. PubMed ID: 32513124
[TBL] [Abstract][Full Text] [Related]
7. Nomogram based on immune-inflammatory indicators and age-adjusted charlson comorbidity index score to predict prognosis of postoperative parotid gland carcinoma patients.
Cheng H; Xu JH; He JQ; Wu CC; Li JF; Xu XL
BMC Oral Health; 2024 Jun; 24(1):718. PubMed ID: 38909208
[TBL] [Abstract][Full Text] [Related]
8. Development and validation of a new clinical staging system to predict survival for esophageal squamous cell carcinoma patients: Application of the nomogram.
Shao CY; Liu XL; Yao S; Li ZJ; Cong ZZ; Luo J; Dong GH; Yi J
Eur J Surg Oncol; 2021 Jun; 47(6):1473-1480. PubMed ID: 33349524
[TBL] [Abstract][Full Text] [Related]
9. Development and Validation of a Nomogram for Predicting Survival in Male Patients With Breast Cancer.
Chen S; Liu Y; Yang J; Liu Q; You H; Dong Y; Lyu J
Front Oncol; 2019; 9():361. PubMed ID: 31139562
[TBL] [Abstract][Full Text] [Related]
10. Nomogram to Predict Overall Survival for Thoracic Esophageal Squamous Cell Carcinoma Patients After Radical Esophagectomy.
Deng W; Zhang W; Yang J; Ni W; Yu S; Li C; Chang X; Zhou Z; Chen D; Feng Q; Chen X; Lin Y; Zhu K; Zheng X; He J; Gao S; Xue Q; Mao Y; Cheng G; Sun K; Liu X; Fang D; Chen J; Xiao Z
Ann Surg Oncol; 2019 Sep; 26(9):2890-2898. PubMed ID: 31183641
[TBL] [Abstract][Full Text] [Related]
11. A Practical Nomogram and Risk Stratification System Predicting Cancer-Specific Survival for Hepatocellular Carcinoma Patients With Severe Liver Fibrosis.
Yang D; Su Y; Zhao F; Chen C; Zhao K; Xiong X; Ding Y
Front Surg; 2022; 9():920589. PubMed ID: 35784933
[TBL] [Abstract][Full Text] [Related]
12. Construction and Validation of a Novel Nomogram to Predict the Overall Survival of Patients With Combined Small Cell Lung Cancer: A Surveillance, Epidemiology, and End Results Population-Based Study.
Jiang A; Liu N; Zhao R; Liu S; Gao H; Wang J; Zheng X; Ren M; Fu X; Liang X; Tian T; Ruan Z; Yao Y
Cancer Control; 2021; 28():10732748211051228. PubMed ID: 34632799
[TBL] [Abstract][Full Text] [Related]
13. A Practical Nomogram and Risk Stratification System Predicting the Cancer-Specific Survival for Patients With Advanced Hepatocellular Carcinoma.
Yang D; Su Y; Zhao F; Chen C; Zhao K; Xiong X; Ding Y
Front Oncol; 2022; 12():914192. PubMed ID: 35903694
[TBL] [Abstract][Full Text] [Related]
14. Establishment and validation of a prognostic nomogram for extrahepatic cholangiocarcinoma.
Zhao F; Yang D; He J; Ju X; Ding Y; Li X
Front Oncol; 2022; 12():1007538. PubMed ID: 36505787
[TBL] [Abstract][Full Text] [Related]
15. Development and validation of a nomogram to predict overall survival for patients with metastatic renal cell carcinoma.
Zheng W; Zhu W; Yu S; Li K; Ding Y; Wu Q; Tang Q; Zhao Q; Lu C; Guo C
BMC Cancer; 2020 Nov; 20(1):1066. PubMed ID: 33148204
[TBL] [Abstract][Full Text] [Related]
16. A Survival Prediction Nomogram for Esophageal Squamous Cell Carcinoma Treated with Neoadjuvant Chemoradiotherapy Followed by Surgery.
Ding T; Liu C; Huang B; Chu L; Wei L; Lin Y; Luo Y; Zhang B; Hong C; Xu Y; Peng Y
Cancer Manag Res; 2021; 13():7771-7782. PubMed ID: 34675672
[TBL] [Abstract][Full Text] [Related]
17. A prognostic nomogram for pancreatic ductal adenocarcinoma patients' all-cause survival in a Surveillance, Epidemiology, and End Results analysis.
Li C; Ren Z; Han D; Wang H; Xu F; Zheng S; Lyu J
Transl Cancer Res; 2020 May; 9(5):3586-3599. PubMed ID: 35117722
[TBL] [Abstract][Full Text] [Related]
18. A nomogram for predicting survival in patients with skin non-keratinizing large cell squamous cell carcinoma: A study based on the Surveillance, Epidemiology, and End Results database.
Zhang J; Yang W; Lian C; Zhao Q; Ming WK; Ip CC; Mu HH; Ching Tom K; Lyu J; Deng L
Front Med (Lausanne); 2023; 10():1082402. PubMed ID: 36873873
[TBL] [Abstract][Full Text] [Related]
19. Nomograms for predicting overall survival and cancer-specific survival in elderly patients with epithelial ovarian cancer.
Cheng H; Xu JH; Kang XH; Wu CC; Tang XN; Chen ML; Lian ZS; Li N; Xu XL
J Ovarian Res; 2023 Apr; 16(1):75. PubMed ID: 37059991
[TBL] [Abstract][Full Text] [Related]
20. A novel LASSO-derived prognostic model predicting survival for non-small cell lung cancer patients with M1a diseases.
Chen H; Huang C; Ge H; Chen Q; Chen J; Li Y; Chen H; Luo S; Zhao L; Xu X
Cancer Med; 2022 Mar; 11(6):1561-1572. PubMed ID: 35128839
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
